[go: up one dir, main page]

GB1390479A - Pharmaceutical composition for treatment of parkinsonism - Google Patents

Pharmaceutical composition for treatment of parkinsonism

Info

Publication number
GB1390479A
GB1390479A GB4183673A GB4183673A GB1390479A GB 1390479 A GB1390479 A GB 1390479A GB 4183673 A GB4183673 A GB 4183673A GB 4183673 A GB4183673 A GB 4183673A GB 1390479 A GB1390479 A GB 1390479A
Authority
GB
United Kingdom
Prior art keywords
compositions
parkinsonism
treatment
pharmaceutical composition
adamantylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4183673A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
I ORCH SINTEZA AKADEMII NAUK L
Original Assignee
I ORCH SINTEZA AKADEMII NAUK L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I ORCH SINTEZA AKADEMII NAUK L filed Critical I ORCH SINTEZA AKADEMII NAUK L
Priority to GB4183673A priority Critical patent/GB1390479A/en
Publication of GB1390479A publication Critical patent/GB1390479A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1390479 Anti parkinson compositions ORDENA TRUDOVOGO KRASNOGO ZNAMENI INSTITUT ORGANICHESKOGO SINTEZA AKADEMII NAUK LATVIISKOI SSR 5 Sept 1973 41836/73 Heading A5B Pharmaceutical compositions having antiparkinson activity comprise 1-adamantylamino-N-glucuronide having the formula: and an inert, solid, pharmaceutically acceptable carrier. The compositions may be administered orally, or rectally in the form of tablets, dragees, capsules, troches, and suppositories. The compositions may also contain cholinergic preparations, tricyclic antidepressants and/or benzodiazepines.
GB4183673A 1973-09-05 1973-09-05 Pharmaceutical composition for treatment of parkinsonism Expired GB1390479A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4183673A GB1390479A (en) 1973-09-05 1973-09-05 Pharmaceutical composition for treatment of parkinsonism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4183673A GB1390479A (en) 1973-09-05 1973-09-05 Pharmaceutical composition for treatment of parkinsonism

Publications (1)

Publication Number Publication Date
GB1390479A true GB1390479A (en) 1975-04-16

Family

ID=10421586

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4183673A Expired GB1390479A (en) 1973-09-05 1973-09-05 Pharmaceutical composition for treatment of parkinsonism

Country Status (1)

Country Link
GB (1) GB1390479A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002049676A2 (en) * 2000-12-19 2002-06-27 California Institute Of Technology Compositions containing inclusion complexes
US7375096B1 (en) 1998-12-04 2008-05-20 California Institute Of Technology Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network
US8110179B2 (en) 2002-09-06 2012-02-07 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8357377B2 (en) 2002-10-09 2013-01-22 Suzie Hwang Pun Cyclodextrin-based materials, compositions and uses related thereto
US8497365B2 (en) 2007-01-24 2013-07-30 Mark E. Davis Cyclodextrin-based polymers for therapeutics delivery
US11464871B2 (en) 2012-10-02 2022-10-11 Novartis Ag Methods and systems for polymer precipitation and generation of particles

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375096B1 (en) 1998-12-04 2008-05-20 California Institute Of Technology Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network
US8277846B2 (en) 2000-12-19 2012-10-02 California Institute Of Technology Complexing agents for compositions containing inclusion complexes
WO2002049676A3 (en) * 2000-12-19 2002-12-27 California Inst Of Techn Compositions containing inclusion complexes
US7018609B2 (en) 2000-12-19 2006-03-28 California Institute Of Technology Compositions containing inclusion complexes
US7166302B2 (en) 2000-12-19 2007-01-23 California Institute Of Technology Complexing agents for compositions containing inclusion complexes
CN100415296C (en) * 2000-12-19 2008-09-03 加州理工学院 Compositions containing inclusion complexes
US7807198B2 (en) 2000-12-19 2010-10-05 California Institute Of Technology Compositions containing inclusion complexes
US7968123B2 (en) 2000-12-19 2011-06-28 California Institute Of Technology Complexing agents for compositions containing inclusion complexes
US8092833B2 (en) 2000-12-19 2012-01-10 California Institute Of Technology Compositions containing inclusion complexes
WO2002049676A2 (en) * 2000-12-19 2002-06-27 California Institute Of Technology Compositions containing inclusion complexes
US8389499B2 (en) 2002-09-06 2013-03-05 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8518388B2 (en) 2002-09-06 2013-08-27 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8314230B2 (en) 2002-09-06 2012-11-20 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US9550860B2 (en) 2002-09-06 2017-01-24 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8110179B2 (en) 2002-09-06 2012-02-07 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8399431B2 (en) 2002-09-06 2013-03-19 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8404662B2 (en) 2002-09-06 2013-03-26 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8475781B2 (en) 2002-09-06 2013-07-02 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8680202B2 (en) 2002-09-06 2014-03-25 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8252276B2 (en) 2002-09-06 2012-08-28 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8580243B2 (en) 2002-09-06 2013-11-12 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8580244B2 (en) 2002-09-06 2013-11-12 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8580242B2 (en) 2002-09-06 2013-11-12 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8603454B2 (en) 2002-09-06 2013-12-10 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8609081B2 (en) 2002-09-06 2013-12-17 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutics delivery
US8357377B2 (en) 2002-10-09 2013-01-22 Suzie Hwang Pun Cyclodextrin-based materials, compositions and uses related thereto
US8497365B2 (en) 2007-01-24 2013-07-30 Mark E. Davis Cyclodextrin-based polymers for therapeutics delivery
US9610360B2 (en) 2007-01-24 2017-04-04 Ceruliean Pharma Inc. Polymer drug conjugates with tether groups for controlled drug delivery
US11464871B2 (en) 2012-10-02 2022-10-11 Novartis Ag Methods and systems for polymer precipitation and generation of particles

Similar Documents

Publication Publication Date Title
GB1236670A (en) Asparaginase having anti-tumor activity and process for preparing the same
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
CA992770A (en) Large-sized and thick compound sleeves of high hardness
GB1390479A (en) Pharmaceutical composition for treatment of parkinsonism
GB1341794A (en) Medicament for the treatment of hepatic disorders
Wilson A double-blind clinical comparison of amoxapine, imipramine, and placebo in the treatment of depression.
GB1402691A (en) Composition of 4-biphenyl acetic acid
GB1442159A (en) Pharmaceutical compositions containing paracetamol
GB1483650A (en) Pharmaceutical preparations based on mesterolone
GB1250421A (en)
GB1132317A (en) Therapeutic compositions
AU471022B2 (en) Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione
GB1118606A (en) Compositions for the treatment of haemorrhoids
GB1474749A (en) Pharmaceutical preparations based on cyproterone
GB1273025A (en) 07alpha-(2',3'-BUTADIEN-2'-YL)-ESTR-4-EN-17beta-OL-3-ONE
GB1277529A (en) Antiinflammatory compositions
GB1468557A (en) Pharmaceutical composition containing hexetidine
GB1404612A (en) Medicinal preparation for use in treating mental disorders
GB1423762A (en) Preparation of secondary amines
GB1340528A (en) Psychotropic medicinal composition
GB1327465A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
GB1294538A (en) Pharmaceutical compositions
GB1454872A (en) Anticonvulsant
GB1268398A (en) Pharmaceutical compositions
NL7411994A (en) Enzyme granules with improved storage stability - by incorporating an antioxidant

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee